作者:
Adrian,Marino-Enriquez [1]
;
Jan Philipp,Novotny [2]
;
Doga C,Gulhan [1]
;
Isabella,Klooster [3]
;
Antuan V,Tran [1]
;
Macy,Kasbo [3]
;
Meijun Z,Lundberg [1]
;
Wen-Bin,Ou [1]
;
Derrick L,Tao [1]
;
Daniel F,Pilco-Janeta [4]
;
Victor Y,Mao [1]
;
Frank T,Zenke [1]
;
Brittaney A,Leeper [5]
;
Prafulla C,Gokhale [3]
;
Glenn S,Cowley [6]
;
Laurence H,Baker [7]
;
Karla V,Ballman [7]
;
David E,Root [2]
;
Joachim,Albers [8]
;
Peter J,Park [9]
;
Suzanne,George [2]
;
Jonathan A,Fletcher [6]
作者单位:
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
[1]
Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
[2]
Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
[3]
Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Sci-Tech University, Hangzhou, China.
[4]
Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology, Autonomous University of Barcelona, Barcelona, Spain.
[5]
Research Unit Oncology, The Healthcare Business of Merck KGaA, Darmstadt, Germany.
[6]
Experimental Therapeutics Core and the Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
[7]
Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
[8]
Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
[9]
Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
[10]
DOI
10.1158/1078-0432.CCR-23-0998
PMID
37773632
发布时间
2024-06-16